Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets.
about
PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity.Integrative meta-analysis of differential gene expression in acute myeloid leukemiaGlobal Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia PatientsProteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses.Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.Lipid mediators and human leukemic blasts.Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia.Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.Innovations, challenges and future prospects of oncoproteomics.Proteomic approaches in myeloid leukemia.α-Enolase: a promising therapeutic and diagnostic tumor target.α-Enolase, a multifunctional protein: its role on pathophysiological situationsThree are better than one: plasminogen receptors as cancer theranostic targets.The use of molecular genetics to refine prognosis in acute myeloid leukemia.Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions.Comparative proteomics in acute myeloid leukemia.The tumor suppressor annexin A10 is a novel component of nuclear paraspeckles.Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity.Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics.Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells.A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs.Proteomic profile of a therapy related acute myeloid leukemia following brain tumor.
P2860
Q30417613-E956C853-1A62-4EAE-B0E3-493B1893E2DFQ33538043-F212ECD6-EC9A-4A3F-B203-216A090255E6Q33555287-48FF5A6C-6A50-4696-9E75-09BFD96692FCQ33659100-15BEB5C6-E9D2-4A29-9DAA-BC4EDA83FE03Q33745000-A2AD67E4-F974-439E-9B72-36A72D160AEFQ34189041-E40F3862-251C-4F0D-9F8D-988DB49A4488Q34816101-DB692929-655E-419D-ADE1-AA332E980490Q35190147-AB16F618-B161-4EEF-97BC-B11FDA9FF142Q36490167-EC298F0D-36DC-4F54-89BC-CD637191B999Q36646486-ABE5EA06-4BC7-4ABD-8BA5-8D9161F0E9C8Q37453835-EF8B4EAA-3F1E-4936-AF12-976CD94D5AC0Q37831255-DD85B748-75FB-43A9-BAE6-64C3BCE39AD6Q37831975-70D56004-3909-4F45-ADDA-3E539BEDD76CQ38057216-6005288C-31D9-4914-91D3-D6428165E1D1Q38099731-5275D6C0-871C-4D11-A350-3D5F43FBC8DAQ38198569-A25A0D16-78DB-4D71-8C6A-29AD5ECE952EQ42263242-75F02EA3-CB9D-4DA4-9BA3-F49A765396A9Q43121205-A6B64834-1A08-4EF9-AD2E-E310AD08CF96Q43442950-CB2F4F86-D395-4817-94D0-57F5B8A20821Q45976740-44708C90-A18B-4FE8-BDDC-90C251DDD4D0Q49805542-CC15E7CC-1537-4EE9-A6AE-0C867995C169Q51135450-E595FF4F-29AB-4B6F-AEEA-5ECE99CD348CQ51510767-3EF7022D-05E9-4B3A-904E-6ECAFACE6061Q54518739-18C916C2-981A-4D0A-A7DD-05FB5E5FB47FQ55378421-8D5166D5-7231-4EB0-B55C-54E3B2901823Q55463794-14C4C01E-89D5-47B8-AA79-39EA199CB7A0
P2860
Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Proteomic analysis of acute my ...... rkers and therapeutic targets.
@ast
Proteomic analysis of acute my ...... rkers and therapeutic targets.
@en
type
label
Proteomic analysis of acute my ...... rkers and therapeutic targets.
@ast
Proteomic analysis of acute my ...... rkers and therapeutic targets.
@en
prefLabel
Proteomic analysis of acute my ...... rkers and therapeutic targets.
@ast
Proteomic analysis of acute my ...... rkers and therapeutic targets.
@en
P2093
P356
P1433
P1476
Proteomic analysis of acute my ...... rkers and therapeutic targets.
@en
P2093
Antonio Rodríguez-Ariza
Antonio Torres
Chary López-Pedrera
Consuelo Gómez-Díaz
Emilio Siendones
Francisco Velasco
José Manuel Villalba
Nuria Barbarroja
Paula Buendía
P2860
P304
P356
10.1002/PMIC.200500384
P478
P577
2006-04-01T00:00:00Z